Arsenal Capital Management

InterShunt is a medical device company based in St. Louis, Missouri, founded in 2015. The company specializes in designing and developing a proprietary catheter-based system aimed at alleviating the symptoms of heart failure. Their innovative approach centers on left atrial decompression, utilizing a minimally invasive procedure that does not require any implants or energy for capturing and excising tissue from the interatrial septum. By enabling healthcare professionals to effectively reduce left atrial pressure, InterShunt seeks to provide significant relief for millions of individuals suffering from heart failure.

Juristat is a provider of a patent analytics platform that leverages public patent data to enhance patent prosecution strategies for law firms and in-house counsel. The platform utilizes a proprietary natural language processing algorithm to analyze the past behaviors of patent examiners at the United States Patent and Trademark Office (USPTO). By generating Examiner Reports, Juristat enables users to predict future examiner behavior, thereby increasing allowance rates and reducing time and costs associated with patent applications. The platform allows for detailed filtering of data based on individual examiners, art units, assignees, application types, and claims, while also tracking behavioral changes over time. Juristat's extensive database includes complete image file wrappers for over 5.5 million patent applications and covers 99% of all active art units and examiners, providing comprehensive insights for optimizing responses to office actions.

Kypha Inc. is a life sciences company focused on the discovery, development, and commercialization of in-vitro diagnostic biomarker tests targeting inflammation and autoimmune disorders. Based in St. Louis, Missouri, the company offers the COMP ACT System, which enhances the monitoring and treatment of various health conditions, including lupus, stroke, traumatic brain injury, preeclampsia, infection, kidney disease, and transplant rejection. Through its innovative platform, Kypha provides rapid and accurate assessments of inflammation levels, enabling healthcare professionals to make timely and informed clinical decisions. The company's approach facilitates testing across diverse settings, from home health care to clinical laboratories, ultimately aiming to improve patient outcomes by optimizing treatment strategies based on real-time immune insights. Since its incorporation in 2009, Kypha has attracted significant funding and built a strong network of scientific and clinical expertise to support its mission.

Deck Commerce is a cloud-based solution platform that focuses on enhancing e-commerce operations for retailers. It addresses challenges related to data integration and business processes in the retail environment. The platform offers features such as enterprise inventory visibility, universal product information, and distributed order management. By connecting front-end shopping channels with back-end business systems, Deck Commerce enables small e-commerce businesses to efficiently manage orders, inventory, and product data, thereby optimizing their operational processes.

Kypha Inc. is a life sciences company focused on the discovery, development, and commercialization of in-vitro diagnostic biomarker tests targeting inflammation and autoimmune disorders. Based in St. Louis, Missouri, the company offers the COMP ACT System, which enhances the monitoring and treatment of various health conditions, including lupus, stroke, traumatic brain injury, preeclampsia, infection, kidney disease, and transplant rejection. Through its innovative platform, Kypha provides rapid and accurate assessments of inflammation levels, enabling healthcare professionals to make timely and informed clinical decisions. The company's approach facilitates testing across diverse settings, from home health care to clinical laboratories, ultimately aiming to improve patient outcomes by optimizing treatment strategies based on real-time immune insights. Since its incorporation in 2009, Kypha has attracted significant funding and built a strong network of scientific and clinical expertise to support its mission.

Aptimmune is a biotechnology company based in St. Louis, Missouri, founded in 2010. The company specializes in developing mucosal vaccines for swine to combat viral diseases, specifically targeting Porcine Reproductive and Respiratory Syndrome virus (PRRSV) and influenza A virus. Aptimmune employs innovative technologies, including its proprietary pig alveolar macrophage cell line ZMAC, to create effective nasal delivery vaccines. These advancements aim to provide animal breeders with lasting immune responses and enhanced disease protection, contributing to the overall health and productivity of swine populations.

Deck Commerce is a cloud-based solution platform that focuses on enhancing e-commerce operations for retailers. It addresses challenges related to data integration and business processes in the retail environment. The platform offers features such as enterprise inventory visibility, universal product information, and distributed order management. By connecting front-end shopping channels with back-end business systems, Deck Commerce enables small e-commerce businesses to efficiently manage orders, inventory, and product data, thereby optimizing their operational processes.

PowerPublish is a virtual newsroom that offers a content publishing platform designed to curate, create, and disseminate premium content for modern brands. By leveraging technology and content automation, PowerPublish enables companies to transform into effective publishers, enhancing their ability to share their voice and establish search authority. The platform facilitates the intelligent and valuable publication of content across various social media channels while also monitoring marketing performance. This comprehensive approach allows businesses to effectively monetize their content and expertise, ensuring a seamless experience in content distribution and audience engagement.

Bonfyre Inc. is an employee engagement platform founded in 2013 and based in Saint Louis, Missouri. The company focuses on transforming workplace culture by providing technology that enhances employee recognition, communication, feedback, and event management. Its mobile-first platform offers real-time communication tools such as announcements, targeted broadcasts, and pop surveys, which help organizations foster camaraderie, align their culture, and gather valuable HR insights. By modernizing employee communications, Bonfyre enables companies to build stronger relationships and increase engagement, ultimately promoting a collaborative and innovative work environment.

Bonfyre Inc. is an employee engagement platform founded in 2013 and based in Saint Louis, Missouri. The company focuses on transforming workplace culture by providing technology that enhances employee recognition, communication, feedback, and event management. Its mobile-first platform offers real-time communication tools such as announcements, targeted broadcasts, and pop surveys, which help organizations foster camaraderie, align their culture, and gather valuable HR insights. By modernizing employee communications, Bonfyre enables companies to build stronger relationships and increase engagement, ultimately promoting a collaborative and innovative work environment.

Harbor MedTech, Inc. is a regenerative medicine company based in Irvine, California, specializing in the development and commercialization of tissue regeneration products. Founded in 2010, the company offers a range of solutions for chronic wounds, hernia and joint repair, and soft tissue reinforcement. Notable products include Architect, an extracellular collagen matrix designed for managing various skin wounds, and EPMatrix, a collagen scaffold aimed at soft tissue repair. The company's innovative BriDGE platform enables the creation of advanced therapies for applications including breast reconstruction, Achilles tendon repair, and rotator cuff repair, as well as other surgical needs in dermatology and general surgery. Harbor MedTech is also engaged in a strategic partnership with Edwards Lifesciences to enhance its product offerings and market reach.

Synek created the SYNEK beer dispenser and personally thanked every backer by taking a 42-city RV tour to deliver the 2,500 pre-ordered dispensers. The SYNEK beer dispenser refrigerates, pressurizes, and dispenses beer in the coolest way possible—brewery-quality beer, fresh on draft, in your home.

Wellopp is a developer of a social health intelligence platform aimed at enhancing chronic care management. The platform utilizes behavioral change and social health technologies to curate data from various social health determinants. By engaging patients through a personalized experience across different aspects of care, Wellopp enables healthcare providers to improve quality, manage costs, and reduce readmission rates. The company targets the significant issue of preventable readmissions in the U.S. healthcare system, which incurs billions in annual losses. By offering solutions that comply with privacy regulations, Wellopp addresses the urgent need for better patient outcomes while providing healthcare systems with a low-cost approach to managing these challenges.

KEW, Inc., established in 2009 and headquartered in Cambridge, Massachusetts, specializes in genomic testing services for cancer patients. The company's core offering, CANCERPLEX, is a precision medicine service that analyzes a patient's genetic drivers to help oncologists select personalized, targeted therapies. KEW's suite of products includes CANCERPLEX FP, a full panel test with immunotherapy options, CANCERPLEX TS for common tumor sites, and CANCERPLEX TX for FDA-approved targeted therapies. The company delivers these solutions through strategic partnerships and distributors, enabling evidence-driven treatment decisions in cancer care.

Kypha Inc. is a life sciences company focused on the discovery, development, and commercialization of in-vitro diagnostic biomarker tests targeting inflammation and autoimmune disorders. Based in St. Louis, Missouri, the company offers the COMP ACT System, which enhances the monitoring and treatment of various health conditions, including lupus, stroke, traumatic brain injury, preeclampsia, infection, kidney disease, and transplant rejection. Through its innovative platform, Kypha provides rapid and accurate assessments of inflammation levels, enabling healthcare professionals to make timely and informed clinical decisions. The company's approach facilitates testing across diverse settings, from home health care to clinical laboratories, ultimately aiming to improve patient outcomes by optimizing treatment strategies based on real-time immune insights. Since its incorporation in 2009, Kypha has attracted significant funding and built a strong network of scientific and clinical expertise to support its mission.

TransMed Systems, Inc. specializes in developing software solutions that enhance the analysis and application of transactional data in the U.S. healthcare system. The company offers a range of products, including the TransMed Suite, which provides an integrated platform for translational medicine that supports the entire workflow from data aggregation to clinical application. Additionally, their Adaptive Healthcare Unified Bioclinical tool enables healthcare data management, while the Clinically Actionable Report Engine translates research findings into practical clinical decision support. The Bio-Informatics Suite accelerates translational research by facilitating data exploration and analysis across various sources. TransMed Systems serves both health sciences researchers and clinicians, focusing on integrating analytics to improve clinical practices. Headquartered in Cupertino, California, the company has offices in Washington, D.C., Chicago, Illinois, and Columbus, Ohio, and maintains a strategic alliance with Pharmatech Inc.